Sign In
Get Clay Free →

Suggestions

    Thomas Klema

    Chief Financial Officer at Housey Pharmaceutical Research Laboratories LLC

    Professional Background

    Tom Klema is a highly accomplished executive in the pharmaceutical and finance industries, bringing a wealth of expertise in capital markets, drug development, and operational leadership. Over the years, he has successfully held prominent positions, including Chief Financial Officer at Housey Pharmaceutical Research Laboratories LLC, where he steered the company's financial strategy and operations. His extensive experience also extends across various other notable organizations, such as Independnet CFO Consultant and Rockwell Medical, Inc., where he made significant contributions to financial planning and corporate governance.

    Klema's career trajectory showcases his capacity to manage and enhance business operations through strategic planning and adept financial management. His proficiency in navigating the complex landscape of public company operations has made him a key asset in the drug and device development sectors. His leadership record in sales and operations planning, distribution network establishment, and compliance with government regulations highlights his versatility in managing diverse operational functions. Additionally, his expertise encompasses crucial aspects like human resources, IT oversight, and accounting, ensuring comprehensive management of all organizational components.

    His previous roles reflect a solid foundation in financial management, which he established during his time as Vice President of Finance and Administration at Whistler Corporation and as Vice President at Diversey Lever within the Molson Companies, Ltd. Furthermore, Klema began his career as a Senior in-Charge Auditor and CPA at a national public accounting firm, underscoring his deep understanding of financial principles and practices.

    Education and Achievements

    Tom Klema's educational background is robust, with advanced degrees in finance and accounting that underpin his practical experience. He earned his Master of Business Administration in Finance from the prestigious Eli Broad College of Business at Michigan State University, complementing his Bachelor of Science degree in Accounting, also from the same university. His foundational education began at Henry Ford College, where he received an Associate of Arts in Business.

    Klema's educational qualifications, coupled with his leadership roles, have equipped him with insights that are vital for navigating the challenges faced by public companies in today's dynamic market landscape. His CPA designation reflects his commitment to the highest standards of accounting and financial practice, adding to his credibility as an expert in the field.

    Throughout his career, Klema has achieved numerous milestones. His extensive experience in capital markets has helped guide organizations through complex financial landscapes, ensuring that stakeholders are well-informed and strategically aligned. His expertise in M&A and investor relations has enabled the companies he has worked with to operate under sound corporate governance and compliance frameworks. This extensive experience has not only sharpened his acumen for financial analysis but has also shaped his ability to effectively communicate with investors and stakeholders, further enhancing organizational growth.

    Achievements

    In his career, Tom Klema has demonstrated excellence across multiple areas of business operations that have helped organizations thrive. His unique combination of financial acumen and operational oversight is evidenced by his role in establishing effective sales and operations planning processes, which streamline operations and focus on organizational efficiency. These initiatives have significantly contributed to the profitability and market positioning of the companies with which he has been associated.

    Klema has also been instrumental in the successful implementation of Enterprise Resource Planning (ERP) systems, showcasing his ability to integrate technology with business processes to enhance efficiency. His leadership in human resources and compliance underscores his holistic understanding of organizational dynamics, making him a well-rounded executive capable of driving change in multifaceted environments.

    As someone deeply familiar with drug and device regulations, Klema’s expertise extends to ensuring that businesses comply with stringent industry standards. This familiarity not only safeguards the companies under his stewardship but also builds trust with stakeholders and the communities they serve.

    His strategic vision and ability to foster relationships within and outside the organization have played a key role in driving corporate initiatives that align with both regulatory requirements and market demands. Through his skillful management of investor relations and proficiency in SEC reporting, Klema has maintained transparency with stakeholders, promoting a culture of trust and integrity.

    In conclusion, Tom Klema exemplifies the qualities of an effective executive leader with a multifaceted background in finance, operations, and drug development. His blend of educational credentials and practical experience not only positions him as a leader within the pharmaceutical industry but also as a valuable asset to any organization that prioritizes strategic growth and operational excellence. As he continues his career, his commitment to fostering innovative solutions and navigating complexities in corporate finance and operations remains steadfast, reflecting his dedication to advancing the fields in which he operates.

    Related Questions

    How did Tom Klema's experience with capital markets shape his approach as a Chief Financial Officer?
    In what ways has Tom Klema contributed to drug development processes at Housey Pharmaceutical Research Laboratories LLC?
    What strategies has Tom Klema implemented in his roles that have positively impacted business operations?
    How does Tom Klema balance compliance with operational efficiency in the pharmaceutical industry?
    What insights can Tom Klema provide about navigating SEC regulations and reporting for public companies?
    Thomas Klema
    Add to my network

    Location

    Southfield, Michigan, United States